Please read — very important
Unsubscribe | Report as spam | Change email preferences
This is an early indicator of prostate trouble
Prostate cancer is a near-constant worry for many men over a certain age.
However, the reality is that most prostate cancer diagnoses are not that serious.
Of course, you never want to hear that diagnosis anyway.
We have been told that male hormones, DHT, testosterone, and genetic predispositions are the drivers of prostate cancer.
But a close reading of the research gives me a different opinion.
Low levels of male hormones, elevated levels of prolactin and estrogen, and bacterial gut imbalances are the major drivers of prostate cancer.
Recently, researchers showed that exposure to estrogens, even in utero, increases the likelihood of prostate cancer later on.
The review of the current research was carried out at the University of Illinois at Chicago. This paper was published in Reproductive Toxicology.
The prostate begins to develop early in mammals – it changes shape in the fetus during pregnancy.
“Prostate morphogenesis occurs in utero in humans and during the perinatal period in rodents.”
Changes in utero are driven by “hormone baths” – usually “male” hormones or “female” hormones.
“While largely driven by androgens, there is compelling evidence for a permanent influence of estrogens on prostatic development.”
When “hormone baths” come at the wrong time or contain inappropriate hormones, they can interfere with development in many ways.
“If estrogenic exposures are abnormally high during the critical developmental period, permanent alterations in prostate morphology and function are observed.”
Excessive estrogen baths in males during development because of something known as estrogenization.
“This process is referred to as developmental estrogenization.”
Some studies have linked this to small penis size, the abnormal distance between the penis and anus, and the likelihood of homosexuality or transgenderism.
In these animal experiments, the researchers showed that high doses of a natural estrogen called estradiol increased the likelihood of prostate cancer in later life.
“Using the neonatal rodent as an animal model, it has been shown that early exposure to high doses of estradiol results in an increased incidence of prostatic lesions with aging.”
Animals exposed early in life to estradiol had numerous prostate changes later on.
Changes indicating an increased risk of prostate cancer.
“Estradiols effects include hyperplasia, inflammatory cell infiltration and prostatic intraepithelial neoplasia or PIN, believed to be the precursor lesion for prostatic adenocarcinoma.”
Prostatic adenocarcinoma is the most common form of prostate cancer, accounting for approximately 95% of cases.
On top of this, other studies have shown that the synthetic estrogen BPA can have similar effects in males exposed to it at a young age.
BPA (bisphenol A) is a compound used in many plastics, including plastic water bottles and food containers.
“Low-dose estradiol exposures as well as exposures to bisphenol A show increased susceptibility to PIN lesions with aging following additional adult exposure to estradiol.”
PIN is prostatic intraepithelial neoplasia. It is not cancer, but it is considered a precancerous condition because it may increase the risk of developing prostate cancer.
The study also showed epigenetic changes in response to early estrogen exposure.
“Gene methylation analysis revealed a potential epigenetic basis for the estrogen imprinting of the prostate gland.”
Epigenetics refers to changes in gene expression that happen without changing the DNA sequence itself.
Epigenetic changes can turn genes on or off and increase or decrease their activity without altering the genetic code.
And so it seems that estrogens rather than male hormones and genetic tendencies are major drivers of prostate cancer – even when those exposures occur very early on in development.
“Our results suggest that a full range of estrogenic exposures during the postnatal critical period results in an increased incidence and susceptibility to neoplastic transformation of the prostate gland in the aging male.”
You should always consult your healthcare practitioner for guidance on medical diagnosis and treatment.
—-Important Message from Dr. Magill—-
My prostate supplement contains the rarely used mushroom agaricus bisporus — because it helps lower estrogen
The rarely used mushroom Agaricus bisporus was discovered around 1650 by a melon grower…
…who decided to cultivate this new exotic delicacy by introducing it in exclusive Parisian restaurants.
Then in 2015, the City of Hope researchers treated 36 patients with this mushroom powder to assess their PSA levels’ responsiveness to different doses of the powder…
…and whether the men experienced any ill effects…
After months of daily use of agaricus bisporus, 36% of the patients in the City of Hope study experienced some reduction in PSA.
Two patients experienced a remarkable complete response, meaning their PSA levels dropped to undetectable levels.
All of this may be because of this magical mushroom’s ability to act as an aromatase inhibitor…
…meaning it helps keep estrogen low while testosterone can soar.
That’s just 1 of the 4 powerhouse ingredients in Urgent Prostate Assist — get your bottle today and take 25% off with the code: UPA25
———-
